MiNK Therapeutics, Inc. (NASDAQ:INKT) Q2 2024 Earnings Call Transcript August 13, 2024
MiNK Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.1.
Operator: Good morning and welcome to MiNK Therapeutics Second Quarter 2024 Conference Call and Webcast. All participants will be in listen-only mode until question-and-answer session. Please note this event is being recorded. If anyone has any objection, you may now disconnect at this time. I would now...
